modelVericiguat_Ruehs2021_reference

Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral.

Information

name:vericiguat
ATC code:C01DX22
model:one compartment, oral dosing (PK_1C_enteral)
source:Ruehs H et al. 2021
population:adults with heart failure and reduced ejection fraction
measured compound:vericiguat
review:accepted with caveats
record page:pharmacolibrary-docs

Parameters as reported in the paper

parametervalueunitmeaning
CL/F (L/h)1.3L/hCL/F
V/F (L)38.9LV/F
ka (1/h)1.51/hkabs
v_sex0.850equation variable
theta_q22_creatinine_power0.164equation variable
theta_kabs_bodyweight_ka1.28equation variable
theta_kabs_albumin_power2.37equation variable

About vericiguat

Vericiguat is a vasodilator used to treat heart failure. It is approved and authorised in the European Union, though it also remains investigational for other uses.

Summary written by glm-5.3-flash from Wikidata Q27283201 and the WHO ATC classification and the EMA medicines list; not checked by a person.

Identity, molar mass and metabolites: Vericiguat.

References

  1. Ruehs H et al. (2021). Population Pharmacokinetics and Pharmacodynamics of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. Clinical pharmacokinetics 60(11):1407–1421. DOI:10.1007/s40262-021-01024-y PUBMED:34086190

Parameters

TypeNameDefaultDescription
RealCl_ref3.611111111111112e-07Cl [m3/s]
Realcov_sex_00sex covariate
RealVd_ref0.0389Vd [m3]
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.0009Volume of distribution per kg (default 0.9 L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)1bioavailability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)2.7777777777777776e-7clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1e-4administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.TransferRateka (from PK_1C_enteral)0.016666666666666666first order absorption rate
Modelica.Units.SI.TimeTlag (from PK_1C_enteral)600delay between oral administration and absorption (default 10min)
Info › Therapeutic range (metadata, not used in equations)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008maximal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Info › Substance metadata
Modelica.Units.SI.MolarMassMM (from PK_1C)0molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0)
Info › Substance metadata (not used in equations)
Pharmacolibrary.Types.DoseLD50 (from PK_1C)0median lethal dose [mg/kg]; 0 = unknown

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models)

Revisions

  • 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Ruehs_2021: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: accepted with caveats